Literature DB >> 21641756

What happens at the adjacent knee joint after total hip arthroplasty of Crowe type III and IV dysplastic hips?

Kasim Kilicarslan1, Nadir Yalcin, Hakan Cicek, Erdal Cila, Hasan Yildirim.   

Abstract

We prospectively evaluated 30 hips of 22 patients who had normal knees with a mean age of 53.4 years (range, 38-72 years). In the early postoperative period, genu valgum deformity was observed in all knees. Of 22 patients, 17 complained of severe pain owing to strain in the medial collateral ligament and iliotibial tract. Postoperatively, the ipsilateral extremities of the patients were extended by a mean of 16.5 mm (8-25 mm). Q angles of the patients increased by a mean of 4.4° ± 2.5° (P < .001). Although the Harris hip scores were improved (40.7-87.8 points), postoperative Lysholm-Gillquist knee scores were significantly reduced (92-76 points, P < .001). Reduction of displaced hips into the anatomical hip center and lengthening the extremity despite shortening procedure may lead to strain at the knee joint iatrogenically, particularly with the mechanical effect of tensor fascia lata, which results with changes in the knee biomechanics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641756     DOI: 10.1016/j.arth.2011.04.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

1.  The ratio of femoral head diameter to pelvic height in the normal hips of a Chinese population.

Authors:  Yanbo Zhang; Jinlan Jiang; Chenyu Wang; Jianlin Zuo; Modi Yang; Jincheng Wang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-08-27

2.  Changes in Distribution of Lower Limb Alignment After Total Hip Arthroplasty for Crowe IV Developmental Dysplasia of the Hip.

Authors:  Jingyang Sun; Lingfei Guo; Ming Ni; Junmin Shen; Yinqiao Du; Bohan Zhang; Guoqiang Zhang; Yonggang Zhou
Journal:  Ther Clin Risk Manag       Date:  2021-05-03       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.